| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $75K | -93.5% |
| R&D Expense | $28.4M | -40.2% |
| SG&A Expense | $19.1M | +11.5% |
| Operating Income | -$47.4M | +25.3% |
| Net Income | -$46.7M | +26.4% |
| EPS (Basic) | -$0.89 | +27.6% |
| EPS (Diluted) | -$0.89 | +27.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.9M | -47.0% |
| Current Assets | $50.7M | -44.1% |
| Total Assets | $51.8M | -45.1% |
| Current Liabilities | $8.9M | -24.9% |
| Total Liabilities | $8.9M | -30.3% |
| Stockholders' Equity | $42.9M | -47.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.5M | +19.2% |
| Capital Expenditures | $84K | +463.4% |
| Investing Cash Flow | -$84K | -463.4% |
| Financing Cash Flow | $4.2M | -61.2% |
| Free Cash Flow | -$46.5M | +19.1% |